Login
Toggle navigation
Videos
Categories
Trending
Interview with Aram Mangasarian, CEO of NOXXON
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Discussing the company's latest data and strategy
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
I speak with OpenText CEO Mark Barrenechea about the company's fiscal Q4 2023 earnings.
00:10:00
Great Bear Resources Excels with High-Grade Gold Discovery in Ontario's Red Lake District
00:00:00
Fortress Bio | Benzinga Healthcare Small Cap Conference - Dr. Lindsay A. Rosenwald - Chairman, President, & CEO, Fortress Biotech Inc.
00:10:00
Exploration Update: SOKOMAN - Moosehead Project Drill Progress
00:10:00
Revisiting the Landscape: Macerich CEO Disputes Notion of A-Quality Regional Mall Decline
00:10:00
Bigtincan with Proactive at ASX Small and Mid Cap Conference | David Keane, CEO, Bigtincan Holdings Ltd (ASX: BTH)
00:10:00
Tesoro Gold: Advancing Chilean Gold Projects
00:10:00
Involvement inventing the breast cancer drug Herceptin and discussed the investment offering for his latest therapeutic development company|H. Michael Shepard , CEO OF ENOSI THERAPEUTICS
00:10:00
Nicholas Eberstadt on Political Economy and 'Men Without Work|Nicholas Eberstadt,Professor,American Enterprise Institute
00:10:00
Exploring Glenn Gould's Musical Ethos and Leonard Cohen's 'Democracy|Joshua Cohen,Professor,University of California, Berkeley
00:10:00
Insights into Battery and EV Manufacturing: CEO Shares Vision | Somphote Ahunai, CEO, Energy Absolute PCL.
00:10:00
Steering Stability: Deng Zhiyi on the Future of China’s Financial Markets | Deng Zhiyi – CEO, China Orient Asset Management Corporation